Cefotiam

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Half-lifeThis section has been translated automatically.

0,7–1 h

Spectrum of actionThis section has been translated automatically.

Bacillus anthracis, Citrobacter spp., Enterobacter spp., E. coli, Haemophilus spp., Klebsiella spp., Moraxella catarrhalis, Morganella morganii, Neisseria spp., Proteus mirabilis, Providencia spp., Salmonella spp., Serratia spp., Shigella spp., Staphylococcus spp.

IndicationThis section has been translated automatically.

Respiratory, urinary tract, skin, soft tissue, bone and joint infections, sepsis, gonorrhea.

Dosage and method of useThis section has been translated automatically.

  • 3 times 1 g to 2 times 2 g/day i.v. or i.m.
  • Children: 50 mg/kg bw/day.
  • Infants: 2-3 times 20 mg/kg bw/day
  • Gonorrhoea: 1 g i.m. as ED.

PreparationsThis section has been translated automatically.

Spizef

Authors

Last updated on: 29.10.2020